再升科技(603601.SH)連續2個漲停 已有醫用防護口罩生產線1條、計劃新增1條產線
格隆匯2月4日丨再升科技(603601.SH)公佈,公司股票於2020 年2 月3日、2 月4 日連續兩個交易日內收盤價格漲幅偏離值累計超過20%,根據《上海證券交易所交易規則》的有關規定,屬於股票交易異常波動。
經公司自查,並向公司控股股東及實際控制人發函問詢得知,確認不存在應披露而未披露的重大信息。
鑑於當前新型冠狀病毒疫情的嚴峻性,落實當地政府要求,公司擬增加從事醫用防護口罩、醫用外科口罩的研發、生產和銷售等經營範圍,截止目前公司已有醫用防護口罩生產線1條,產能50萬個/月,計劃新增1條產線,預計產能50萬個/月。公司主營業務未發生變化,經營範圍調整預計對公司當年經營業績影響較小,敬請廣大投資者理性投資,注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.